WebSphingoTec 1571 seguidores en LinkedIn. Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support … WebSphingoTec GmbH develops innovative biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute kidney injury, sepsis, and acute heart failure, in …
Grafický manuál a logá SPU Nitra - uniag.sk
WebSHIPTECH logo . Odborné cenové podklady . Na základe zaslaných údajov pre vás vypracujeme odbornú cenovú ponuku. Formulár vám pomôže presne zadefinovať údaje … WebSphingoTec GmbH develops innovative biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute kidney injury, sepsis, and acute heart failure, in … SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction, and … Sometimes, in critically ill patients, the underlying pathomechanism behind the … SphingoTec develops and markets innovative biomarkers for acute medical … SphingoTec is a privately held company with its headquarter in Hennigsdorf near … About us . SphingoTec GmbH develops innovative biomarkers for diagnosis, … About us . SphingoTec GmbH develops innovative biomarkers for diagnosis, … SphingoTec GmbH Neuendorfstr. 15A 16761 Hennigsdorf, Germany. phone: + … The microtiter plate is a standard tool in analytical research and diagnostic … energy efficient electric towel rail
SphingoTec and Rivaara Labs Close Exclusive Distribution …
Web8. okt 2024 · HENNIGSDORF, Germany, Oct. 8, 2024 /PRNewswire/ -- German diagnostics company sphingotec GmbH has closed a €20m growth equity financing round led ... HENNIGSDORF, Germany, Oct. 8, 2024 ... Web6. sep 2024 · NEW YORK — SphingoTec's recent launchof a CE-marked test foreshadows a strategic move that involves taking novel biomarkers previously available as manual microtiter-based assays and marketing them on a fully automated, microfluidic immunoassay platform suitable for use at the point of care. http://slomatec.trade.sk/ dr courtney liebling